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Introduction
• What influences choice
– Pharmaceutical companies
• GH support systems
– Devices
– Patient choice
– Nurse / Doctor
– GH indications
– CCG
• How does choice work
• Nurses’ roles
– Concordance
• How can we enhance the choice process
GH Support Systems
Company DVD Literature Home 
Nurse Team
Dedicated 
Nurse Team
Helpline Drug 
delivery
Text 
reminder
Download 
info
Lilly ü ü ü x ü ü x x
Ferring ü ü ü x ü ü x x
Ipsen ü ü ü ü ü ü x x
Novo ü ü ü ü ü ü x x
Pfizer ü ü ü x ü ü x x
Sandoz ü ü ü x ü ü ü ü
Merck 
Serono
ü ü ü ü ü ü ü ü
GH Company DVDs
Ferring booklets
GH Company booklets
GH Company booklets
GH additional support
Other incentives – shown at demo?
• Books
• Posters
• Stickers
• Reward charts
• Height charts
• Removable pen covers
• Cool bags
• Bags
• Water bottles
• Fridge magnets
• Phone charms
• Soft toys
• Magazines
• Cameras
Growth Hormone App
Enhanced Nurse Services
• Merck Serono
• Ipsen
• Novo Nordisk
GH devices
Needle free devices
Patient choice – what are the issues?
• Ease of use
• Needle free
• Colour
• Quietness
• Size
• Needle guard
• ‘Feel’
• Automatic needle insertion
• Reduced time holding device against the skin post 
injection
(Wickramasuriya, 2005)
Easypod – Dahlgren 2007
• ‘Very useful’ features:
– Pre-programmed dose 
feature
– Skin sensor
– On screen instructions
– Display of remaining 
dose
– Confirmation of injected 
dose
– Automatic needle 
attachement
Difference of opinion?
• Various comfort settings
• Dose history
• ‘Teach Me’ menu
• Multi-lingual  
instructions
• Refrigeration
• Homecare
• Reconstitution
How well do we know our patients?
• Need to understand parental perceptions and 
beliefs concerning illness and treatment (Van 
Dongen, 2012)
• Discussions of the patients’ view of the 
disease and their expectations of the 
treatment (Haverkamp, 2008)
– Shown to increase concordance (Spoudeas, 2014; 
Van Dongen, 2012; Cutfield, 2011; Haverkamp, 
2008; Kapoor, 2008)
Nurse / Doctor influence?
• Do we always know what is best for our 
patients?
• Need a thorough, more detailed 
understanding
• Nurses in the prime position to know the 
children and their families more closely
– Families have our contact details
– Contact us with queries / concerns
– Main point of liaison for families
GH licenses held in the UK
Company GHD TS SGA PWS CRI SHOX
Lilly
Humatrope
ü ü ü x ü ü
Ferring
Zomacton
ü ü x x x x
Ipsen
NutropinAq
ü ü x x ü x
Novo – Nordisk
Norditropin Simplexx
ü ü ü x ü x
Pfizer
Genotropin
ü ü ü ü ü x
Sandoz
Omnitrope
ü ü ü ü ü x
Merck – Serono
Saizen
ü ü ü x ü x
But how does this work in practice?
• Children with learning difficulties
– Septo Optic Dysplasia
• Need for quick injection → Zomajet
• Visual problems → Easypod, digital pen devices
• Teenagers
– Something small, discreet, disposable → Miniquick
• Girls with Turner syndrome
– Manual dexterity issues  → Easypod, Zomajet
– Larger doses needed → Easypod, Humatropen (20,24mg)
• Travelling families / children with more than one home
– Think about non-refrigeration → Miniquick, Norditropin
But how does this work in practice?
• SGA
– Reduced s/c fat →
• Want more control over administering the injection
– No autoinjectors
• Smallest needle, small vial sizes (4mg, 5mg, 5.3mg)
• Control taken away → Easypod
• Post oncology patients → Zomajet
• Fear of needles
– Needle free → Zomajet
– Needle covers → Nutropin Aq, Genotropin pen and 
Miniquick, Nordipenmate, SurePal
NICE / CCG
• The choice of product should be made on an 
individual basis after informed discussion 
between the responsible clinician and parent / 
carer
• Take into consideration therapeutic need and the 
likelihood of adherence to treatment
• After the discussion, if more than one is suitable, 
the least costly product should be chosen
££££
How does choice work around the UK?
• Department has limited choice v.
• Free choice of all devices
– Do we all give patient choice?
• 89% of 52 centres surveyed do (BSPED audit 2008/2009)
• CNS
– Chat in clinic
– Demonstrates all devices
– Posts out DVDs – follow up phone call
– Clinic appointment
Informed choice?
Nurses’ roles – how to increase 
concordance
• Initial meeting with children and families (Smith 
1992)
– Non judgemental, flexible approach (Haverkamp, 
2008)
• Spend time with the child and family
– Get to know their concerns and fears
– Get the concordance agreement right
• Free patient choice of device (Kapoor, 2008)
• Enhanced support
• Education for patients (Cutfield, 2011)
– Nearing adolescence
• Opinions on their device may change..
How can we enhance the choice process?
• ? Involve other patients (Van Dongen, 2012)
– GH support days
– Group demonstration sessions
• ? Courses for children for self-adminstration
– Age 10 / 11 (Van Dongen, 2012)
• Freedom of choice of all devices (Spoudeas, 2014; 
Van Dongen 2012; Kirk, 2010)
• Explore technology
– Text messaging
– Apps
Still remember the child
Conclusion
• Clinical Nurse Specialists in the best position to 
foster a close relationship with children and their 
families
• Advanced nursing roles
– Nurse led clinics
– Advance patient care with more time
• Educate the children and families more on their condition, 
and about GH devices
• Get to know the families and the implications of their 
conditions
• More and more CNSs becoming Independent Prescribers 
and Advanced Nurse Practitioners
Are we the future…?
Thank you
